Fovea Pharmaceuticals is a French biopharmaceutical company that discovers and develops drugs for the treatment of ocular diseases.
Business Model:
Revenue: $0
Employees: 1-10
Fovea Pharmaceuticals was acquired by
Sanofi.
The acquisition happend on 2009-10-01.
Details of the transaction were not public
Address:
City: Paris
State: Ile-de-France
Zip:
Country: France
Fovea Pharmaceuticals is a French biopharmaceutical company. It discovers and develops drugs for the treatment of ocular diseases. The company offers FOV1101 Prednisporin for the treatment of allergic conjunctivitis; FOV2302, a proprietary plasma kallikrein-kinin inhibitor for the systemic treatment of hereditary angioedema; FOV2304 for the treatment of diabetic macular edema; and FOV2501, an intravitreal formulation of RdCVF designed to treat retinitis pigmentosa with extension to dry age-related macular degeneration. Fovea Pharmaceuticals was founded in 2005 and is based in Paris, France. As of October 30, 2009, it operates as a subsidiary of Sanofi.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2007 | Series B | 6 | $30M |
Abingworth Credit Agricole CIB Forbion Capital Partners Gimv Sofinnova Partners Wellcome Trust Abingworth Credit Agricole CIB Forbion Capital Partners Gimv Sofinnova Partners Wellcome Trust |
11/2005 | Series A | 3 | $24.2M |
Credit Agricole CIB Gimv Sofinnova Partners Credit Agricole CIB Gimv Sofinnova Partners |
3/2007 | Series B | $52.8M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|